Attached files
| file | filename |
|---|---|
| EX-99.1 - PRESS RELEASE - ARTHROCARE CORP | dex991.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 24, 2009
ARTHROCARE CORPORATION
(Exact name of registrant as specified in its charter)
| Delaware | 0-027422 | 94-3180312 | ||
| (State or other jurisdiction of Incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification Number) |
7500 Rialto Blvd., Building Two, Suite 100, Austin, TX 78735
(Address of principal executive offices, including zip code)
(512) 391-3900
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2 below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 14e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.02. Results of Operations and Financial Condition
On November 24, 2009, ArthroCare Corporation issued a press release reporting its filing of its Quarterly Report on Form 10-Q for the quarter ended September 30, 2009. The press release, a copy of which is furnished as Exhibit 99.1 to this report, is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits
| 99.1 | Press release dated November 24, 2009. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| ARTHROCARE CORPORATION | ||||
| Date: November 24, 2009 | By: | /S/ DAVID FITZGERALD | ||
| David Fitzgerald | ||||
| President and Chief Executive Officer | ||||